111 related articles for article (PubMed ID: 23952105)
41. Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression.
Cavagna M; Maldonado LG; de Souza Bonetti TC; de Almeida Ferreira Braga DP; Iaconelli A; Borges E
Fertil Steril; 2010 Jun; 94(1):167-72. PubMed ID: 19342035
[TBL] [Abstract][Full Text] [Related]
42. IVF outcome in patients with orthotopically transplanted ovarian tissue.
Dolmans MM; Donnez J; Camboni A; Demylle D; Amorim C; Van Langendonckt A; Pirard C
Hum Reprod; 2009 Nov; 24(11):2778-87. PubMed ID: 19671623
[TBL] [Abstract][Full Text] [Related]
43. Menstrual cycle synchronization, ovarian stimulation, and in vitro fertilization in olive baboons (Papio anubis): a prospective randomized study.
Nyachieo A; Spiessens C; Chai DC; Mwenda JM; D'Hooghe TM
Fertil Steril; 2009 Feb; 91(2):602-10. PubMed ID: 18328482
[TBL] [Abstract][Full Text] [Related]
44. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome.
Sahu B; Ozturk O; Ranierri M; Serhal P
Arch Gynecol Obstet; 2008 Mar; 277(3):239-44. PubMed ID: 17899140
[TBL] [Abstract][Full Text] [Related]
45. A high number of oocytes obtained after ovarian hyperstimulation for in vitro fertilization or intracytoplasmic sperm injection is not associated with decreased pregnancy outcome.
Kok JD; Looman CW; Weima SM; te Velde ER
Fertil Steril; 2006 Apr; 85(4):918-24. PubMed ID: 16580375
[TBL] [Abstract][Full Text] [Related]
46. Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue: 8-year experience in cancer patients.
Kim SS; Lee WS; Chung MK; Lee HC; Lee HH; Hill D
Fertil Steril; 2009 Jun; 91(6):2349-54. PubMed ID: 18675964
[TBL] [Abstract][Full Text] [Related]
47. Timing of fertility preservation procedures in a cohort of female patients with cancer.
Jenninga E; Louwe LA; Peters AA; Nortier JW; Hilders CG
Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):170-3. PubMed ID: 22137982
[TBL] [Abstract][Full Text] [Related]
48. Oocyte cryopreservation in a woman with mosaic Turner syndrome: a case report.
Kavoussi SK; Fisseha S; Smith YR; Smith GD; Christman GM; Gago LA
J Reprod Med; 2008 Mar; 53(3):223-6. PubMed ID: 18441731
[TBL] [Abstract][Full Text] [Related]
49. Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a randomized, controlled trial.
Baerwald A; Anderson P; Yuzpe A; Case A; Fluker M
Fertil Steril; 2012 Oct; 98(4):881-7.e1-2. PubMed ID: 22819187
[TBL] [Abstract][Full Text] [Related]
50. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients.
Grifo JA; Noyes N
Fertil Steril; 2010 Feb; 93(2):391-6. PubMed ID: 19439285
[TBL] [Abstract][Full Text] [Related]
51. Poor ovarian response in patients younger than 35 years: is it also a qualitative decline in ovarian function?
Figueira Rde C; Braga DP; Nichi M; Madaschi C; Semião-Francisco L; Iaconelli A; Borges E
Hum Fertil (Camb); 2009; 12(3):160-5. PubMed ID: 19544121
[TBL] [Abstract][Full Text] [Related]
52. Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents.
Elizur SE; Chian RC; Pineau CA; Son WY; Holzer HE; Huang JY; Gidoni Y; Levin D; Demirtas E; Tan SL
Rheumatology (Oxford); 2008 Oct; 47(10):1506-9. PubMed ID: 18660508
[TBL] [Abstract][Full Text] [Related]
53. Outcome from consecutive ICSI cycles in patients treated with recombinant human LH and those supplemented with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol.
Fábregues F; Creus M; Casals G; Carmona F; Balasch J
Gynecol Endocrinol; 2013 May; 29(5):430-5. PubMed ID: 23350573
[TBL] [Abstract][Full Text] [Related]
54. Fertility preservation for social indications: a cost-based decision analysis.
Hirshfeld-Cytron J; Grobman WA; Milad MP
Fertil Steril; 2012 Mar; 97(3):665-70. PubMed ID: 22265038
[TBL] [Abstract][Full Text] [Related]
55. Present and future fertility preservation strategies for female cancer patients.
Georgescu ES; Goldberg JM; du Plessis SS; Agarwal A
Obstet Gynecol Surv; 2008 Nov; 63(11):725-32. PubMed ID: 18928577
[TBL] [Abstract][Full Text] [Related]
56. Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications.
Garcia-Velasco JA; Domingo J; Cobo A; Martínez M; Carmona L; Pellicer A
Fertil Steril; 2013 Jun; 99(7):1994-9. PubMed ID: 23465707
[TBL] [Abstract][Full Text] [Related]
57. [Intracytoplasmic sperm injection using cryopreserved-thawed testicular spermatozoa with testicular fine needle aspiration].
Teng XM; Zhu LP; Li KM; Wang Y; Yao HX; Shao JY
Zhonghua Nan Ke Xue; 2005 Jul; 11(7):517-9. PubMed ID: 16078670
[TBL] [Abstract][Full Text] [Related]
58. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
[TBL] [Abstract][Full Text] [Related]
59. Fertility-preservation counselling and treatment for medical reasons: data from a multinational network of over 5000 women.
von Wolff M; Dittrich R; Liebenthron J; Nawroth F; Schüring AN; Bruckner T; Germeyer A
Reprod Biomed Online; 2015 Nov; 31(5):605-12. PubMed ID: 26380870
[TBL] [Abstract][Full Text] [Related]
60. [Do controlled ovarian hyperstimulations and cryopreservations promote recurrences after breast cancer?].
Bergamini ML; Maugard CM; Mathelin C
Gynecol Obstet Fertil Senol; 2017 Mar; 45(3):172-179. PubMed ID: 28259703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
